JPG BioTech is building next-generation treatments for the people grappling with some of the toughest diseases — beginning with prostate cancer, and a focus on the communities it affects most.
We develop assets to treat cancer while considering the social determinants and the etiology behind the disease — pairing the best science with the best engagement for everyone on the team.
Targeted treatments that combine a monoclonal antibody, a linker, and a potent payload to attack tumor cells while sparing healthy tissue.
An approach that accounts for individual variability in genes, environment, and lifestyle — replacing one-size-fits-all care with targeted treatment.
Understanding how genes and the environment interact to drive complex diseases like cancer — opening new paths to diagnosis and treatment.
A clear look at what cancer is, how solid and blood cancers differ, and how tumors form, grow, and evade the body’s defenses.
Our initial target. We pay particular attention to why Black men carry a disproportionate burden of this disease — and what can be done.
Justice for those who have been overlooked and underutilized — addressing the disparities that shape who cancer affects, and how.
Whether you’re a potential partner, researcher, or care provider, we’d love to connect and explore how we can work together.
Start a Conversation